John F Crowley
CIK 1400973 · Executive Chairman · last filed 2024-03-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$359.1K
Companies
3
Total Filings
233
Lifetime Open-Market Net
-$53.88M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Executive Chairman | 991,908 | $14.49 | $14.37M | -$52.33M | 193 | 2024-03-15 |
| NTLA | Director | 11,716 | $11.10 | $130.0K | -$1.60M | 6 | 2023-06-16 |
| TRDA | Director | 37,864 | $6.05 | $229.1K | $48.6K | 4 | 2023-06-12 |
Recent Filings · Page 6 of 24
233 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-12 | TRDA | Grant (A) | — | $0 | EDGAR |
| 2023-06-05 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −6,044 | -$68.7K | EDGAR |
| 2023-06-01 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Notice (144) | −6,044 | -$68.1K | EDGAR |
| 2023-05-17 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −6,044 | -$67.6K | EDGAR |
| 2023-05-15 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Notice (144) | −6,044 | -$68.2K | EDGAR |
| 2023-05-03 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −6,044 | -$71.3K | EDGAR |
| 2023-05-01 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Notice (144) | −6,044 | -$69.7K | EDGAR |
| 2023-04-19 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −6,044 | -$70.5K | EDGAR |
| 2023-04-05 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −6,044 | -$67.8K | EDGAR |
| 2023-03-17 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −6,044 | -$68.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.